Public pressure is growing for the Government to fund the melanoma drug Keytruda, listed as ‘low priority’ by drug funding […]
Continue readingpharmaceuticals
Transparency needed in cancer drug markets – Expert reaction
Experts are calling for greater transparency and fairness in cancer drug pricing, in light of findings revealing discrepancies between Europe, […]
Continue readingAlzheimer’s drug announcement – expert reaction
Scientists are cautiously optimistic about new data indicating the drug solanezumab can slow the progression of Alzheimer’s disease – if […]
Continue readingGlaxoSmithKline concedes drug fraud charges
Pharmaceutical giant GlaxoSmithKline today announced it will plead guilty to marketing drugs for unapproved uses and failing to report safety […]
Continue readingResearch raises concern over sleeping pills
New research has found that several commonly prescribed sleeping pills are associated with a more than fourfold increased risk of […]
Continue reading